Takeda Pharmaceutical Company Limited Trade Receivables
Takeda Pharmaceutical Company Limited (TAK) had Trade Receivables of JPY 651.41 billion as of 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Notes › Receivables
ifrs-full:TradeReceivables · last filed 2025-06-25
- 2025-03-31: Trade Receivables 651.41B JPY.
- 2024-03-31: Trade Receivables 612.44B JPY.
- 2023-03-31: Trade Receivables 575.43B JPY.
- 2022-03-31: Trade Receivables 617.52B JPY.
| Period end | Trade Receivables |
|---|---|
| 2025-03-31 | 651.41B JPY 20-F · filed 2025-06-25 |
| 2024-03-31 | 612.44B JPY 20-F · filed 2025-06-25 |
| 2023-03-31 | 575.43B JPY 20-F · filed 2024-06-26 |
| 2022-03-31 | 617.52B JPY 20-F · filed 2023-06-28 |
| 2021-03-31 | 707.49B JPY 20-F · filed 2022-06-29 |
| 2020-03-31 | 670.71B JPY 20-F · filed 2021-06-29 |
| 2019-03-31 | 657.68B JPY 20-F · filed 2020-06-24 |